UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 5, 2024 4:30 P.M.

Form:	S-3
CIK: 0001420565 Company Name: AILERON THERAPEUTICS INC File Number: 333-276746